| 货号 | HT188026 |
|---|
| 产品名称 | Research Grade Anti-CD28 & EGFR Bispecific Antibody (REGN7075) |
|---|
| 中文品名/别名 | bsAb7075, REGN-7075, Regn 7075 |
|---|
| 包装规格 | 100ug / 1mg |
|---|
| 反应种属 | Human |
|---|
| 应用实验 | ELISA, Bioactivity: FACS, Functional assay, Research in vivo |
|---|
| 状态 | Liquid |
|---|
| 纯度 | >95% purity as determined by SDS-PAGE. |
|---|
| 储存温度 | -20℃ |
|---|
| 运输方式 | 普通冰袋 |
|---|
| 靶点 | T-cell-specific surface glycoprotein CD28, TP44, CD28, CD28, Epidermal growth factor receptor, EC:2.7.10.1, Proto-oncogene c-ErbB-1, Receptor tyrosine-protein kinase erbB-1, EGFR |
|---|
| 基因号 | P10747 & P00533 |
|---|
| 宿主/表达体系 | Human |
|---|
| 交货期 | 现货 |
|---|
| 说明 | Anti-CD28 & EGFR Bispecific Antibody (Regn7075) ( HT188026 ) is a research-grade recombinant antibody targeting CD28 . Produced in mammalian cells with native-like glycosylation. Highlights Research Grade — For PK/PD studies, assay development, and ADA research. Native Glycosylation — Mammalian expression ensures native-like patterns. |
|---|